BackgroundDespite improved availability of COVID-19 vaccines in Sub-Saharan Africa, vaccination campaigns in the region have struggled to pick up pace and trail the rest of the world. Yet, a successful vaccination campaign in Sub-Saharan Africa will be critical to containing COVID-19 globally.MethodsHere, we present new descriptive evidence on vaccine hesitancy, uptake, last-mile delivery barriers, and potential strategies to reach those who remain unvaccinated. Our data comes from national high frequency phone surveys in six countries in East and West Africa with a total population of 415 million people. Samples were drawn from nationally representative samples of households interviewed in recent in-person surveys. Our estimates are based ...
The introduction of effective vaccines in December 2020 marked a significant step forward in the glo...
COVID-19 vaccine coverage in most countries in Africa remains low. Determinants of uptake need to be...
The accelerated development of coronavirus disease (COVID-19) candidate vaccines is intended to achi...
BackgroundDespite improved availability of COVID-19 vaccines in Sub-Saharan Africa, vaccination camp...
Background: COVID-19 vaccination efforts are lagging in Sub-Saharan Africa, as just over 20 percent ...
There is very limited data on the extent and determinants of COVID-19 vaccine hesitancy among adults...
The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatmen...
Vaccine hesitancy (VH) is the seventh among the WHO’s top 10 threats to global public health, which ...
COVID-19 is a major public health threat associated with the increased global burden of infectious d...
Abstract Background Vaccination against the novel coronavirus is one of the most effective strategie...
Objective To identify, describe and map the research tools used to measure COVID-19 vaccine hesitan...
Abstract Background Vaccine inequity is a reality facing the Sub-Saharan Africa region as vaccine na...
Summary Background As vaccination campaigns are deployed worldwide, addressing vaccine hesitancy is ...
Background: To date, COVID-19 vaccine coverage in the African region falls far too short of global g...
As Africa prepares to overcome the difficult challenges of COVID-19 vaccination roll-outs, a number ...
The introduction of effective vaccines in December 2020 marked a significant step forward in the glo...
COVID-19 vaccine coverage in most countries in Africa remains low. Determinants of uptake need to be...
The accelerated development of coronavirus disease (COVID-19) candidate vaccines is intended to achi...
BackgroundDespite improved availability of COVID-19 vaccines in Sub-Saharan Africa, vaccination camp...
Background: COVID-19 vaccination efforts are lagging in Sub-Saharan Africa, as just over 20 percent ...
There is very limited data on the extent and determinants of COVID-19 vaccine hesitancy among adults...
The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatmen...
Vaccine hesitancy (VH) is the seventh among the WHO’s top 10 threats to global public health, which ...
COVID-19 is a major public health threat associated with the increased global burden of infectious d...
Abstract Background Vaccination against the novel coronavirus is one of the most effective strategie...
Objective To identify, describe and map the research tools used to measure COVID-19 vaccine hesitan...
Abstract Background Vaccine inequity is a reality facing the Sub-Saharan Africa region as vaccine na...
Summary Background As vaccination campaigns are deployed worldwide, addressing vaccine hesitancy is ...
Background: To date, COVID-19 vaccine coverage in the African region falls far too short of global g...
As Africa prepares to overcome the difficult challenges of COVID-19 vaccination roll-outs, a number ...
The introduction of effective vaccines in December 2020 marked a significant step forward in the glo...
COVID-19 vaccine coverage in most countries in Africa remains low. Determinants of uptake need to be...
The accelerated development of coronavirus disease (COVID-19) candidate vaccines is intended to achi...